UK markets closed

Immutep Limited (IMMP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.9500+0.0700 (+2.42%)
As of 02:26PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.8800
Open2.8800
Bid2.8700 x 100
Ask3.0200 x 100
Day's range2.8700 - 3.0600
52-week range1.5000 - 3.9000
Volume164,819
Avg. volume219,663
Market cap370.656M
Beta (5Y monthly)1.79
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?

    Wednesday, Immutep Limited (NASDAQ:IMMP) released preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial evaluating eftilagimod alpha (efti) in combination with Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma patients (1L HNSCC) with negative PD-L1 expression. The investigational immuno-oncology combination demonstrates an overall response rate (ORR) of 26.9% and diseas

  • Simply Wall St.

    Immutep Limited (ASX:IMM): Is Breakeven Near?

    Immutep Limited ( ASX:IMM ) is possibly approaching a major achievement in its business, so we would like to shine some...

  • Insider Monkey

    11 Best ASX Stocks To Buy Now

    In this piece, we will take a look at the 11 best ASX stocks to buy now. If you want to skip our introduction to the Australian stock market, then you can take a look at the 5 Best ASX Stocks To Buy Now. With a market capitalization of $1.5 trillion, the Australian stock exchange, […]